Abstract
Background This study aimed to report the characteristics and outcomes of severe leptospirosis patients admitted to the ICU and to find the predictors of ICU admission.
Methods This is a retrospective study of patients diagnosed as leptospirosis either from a serology diagnosis or Thai Lepto score (TLS) > 4. Patients were divided into ICU and general ward cases. All data were compared.
Results Sixty-eight patients with severe leptospirosis were included. Thirty-two patients were ICU admission. ICU patients had higher SOFA score (9.8 ± 2.7 vs 4.6 ± 2.7; p = 0.001), higher TLS (7.6 ± 2.7 vs 5.7 ± 2.4; p < 0.001), lower hematocrit (32.7 ± 7.5% vs 36.6 ± 7.9%; p = 0.04), lower platelet count (88.7 ± 92.2 vs 173.3 ± 84.6 × 1000 cell/mm3; p = 0.008), higher total bilirubin (6.2 ± 6.3 vs 3.0 ± 3.6 mg/dL; p = 0.01), lower serum albumin (3.0 ± 0.5 vs 3.4 ± 0.7 g/dL; p = 0.03), higher creatinine (4.2 ± 2.4 vs 2.8 ± 2.1 mg/dL; p = 0.02), higher requirements for vasopressor or inotrope (90.6% vs 11.1%; p < 0.001), more mechanical ventilator support (84.4% vs 5.5%; p < 0.001), more renal replacement therapy (37.5% vs 0%; p < 0.001), higher hospital mortality (12.5% vs 0%; p = 0.03), and greater length of hospital stay (10.2 ± 5.1 vs 6.5 ± 5.1 days; p = 0.004). The TLS, mechanical ventilator support, and inotrope or vasopressor support were among the independent factors for ICU admission. A TLS > 6 indicated ICU admission.
Conclusion The TLS, inotrope or vasopressor requirement, and mechanical ventilator support were the independent factors for ICU admission. TLS > 6 indicated ICU admission.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Not applicable
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos